Family · Pharmaceutical analytical standards
Cisatracurium
A non-depolarising muscle relaxant of the benzylisoquinoline family, synthesised in 1989 and approved in 1995: in anaesthesia and intensive care it relaxes the muscles for intubation and mechanical ventilation. This family brings together the active ingredient, pharmacopoeial impurities and other impurities.
Did you know?It is one of the ten stereoisomers of atracurium and breaks down on its own in the blood, by Hofmann elimination, at normal body temperature and pH, without needing the liver or kidneys.
No product matches your search.
EDQM standards 4
The official European Pharmacopoeia standards for this family.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.
